ATR and major depressive disorder: Emerging preclinical and clinical evidence posits that ATR may represent a promising therapeutic candidate for addressing unmet needs in neurodegenerative disorders (e.g., Alzheimer’s disease), psychiatric conditions (e.g., depression), and chronic inflammatory diseases (e.g., ulcerative colitis) [12,13].